The conduit repair using Adapt treated tissue is potentially very valuable ... BUT... assuming a design and manufacture plan that works is finalised ( which we have not been told it is) there is still a long way to go until we have a product approved for mass sales.
Animal trials, human trials, applications for approval etc.As a guesstimate assume 3 years and $5 million dollars (US) ... what I am getting at is that it would seem to be out of our reach money-wise and time-wise.
Don't forget that we have the catheter implants into large (size) animals in the next few months which will drain our funds.
Back to being broke by Xmas? What do others here think?
.
Cardiovascular News, page-14
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |